Ultragenyx Pharma (RARE) PT Lowered to $72 at RBC Capital
Tweet Send to a Friend
RBC Capital analyst Luca Issi lowered the price target on Ultragenyx Pharma (NASDAQ: RARE) to $72.00 (from $77.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
